Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.49 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1270876 | 0.84 | PTGS2 (0.62) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL7216291 | 0.84 | PTGS2 (0.62) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL2466828 | 0.81 | CHRNA7 (0.66) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL5309196 | 0.81 | CHRNA7 (0.66) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL7210614 | 0.80 | PTGS2 (0.63) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL7212037 | 0.80 | PTGS2 (0.63) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL8506069 | 0.79 | PTGS2 (0.41) | PTGS2PTGS1CHRNA7 | |
| SCHEMBL7216347 | 0.79 | CHRNA7 (0.70) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL447130 | 0.78 | PTGS2 (0.64) | PTGS2PTGS1CHRNA7CA1CA2 | |
| SCHEMBL7215890 | 0.78 | PTGS2 (0.60) | PTGS2PTGS1CHRNA7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | disclosed |